» Articles » PMID: 38794734

New Perspectives for Low Muscle Mass Quantity/Quality Assessment in Probable Sarcopenic Older Adults: An Exploratory Analysis Study

Abstract

Background: Low muscle mass quantity/quality is needed to confirm sarcopenia diagnosis; however, no validated cut-off points exist. This study aimed to determine the diagnostic accuracy of sarcopenia through muscle mass quantity/quality parameters, using the bioimpedance analysis (BIA), isokinetic, and ultrasound tools in probable sarcopenic community-dwelling older adults (≥60 years). Also, it aimed to suggest possible new cut-off points to confirm sarcopenia diagnosis.

Methods: A cross-sectional exploratory analysis study was performed with probable sarcopenic and non-sarcopenic older adults. BIA, isokinetic, and ultrasound parameters were evaluated. The protocol was registered on ClinicalTrials.gov (NCT05485402).

Results: A total of 50 individuals were included, 38 with probable sarcopenia (69.63 ± 4.14 years; 7 men and 31 women) and 12 non-sarcopenic (67.58 ± 4.54 years; 7 men and 5 women). The phase angle (cut-off: 5.10° men, = 0.003; 4.95° women, < 0.001), peak torque (cut-off: 66.75 Newtons-meters (N-m) men, < 0.001; 48.35 N-m women, < 0.001), total work (cut-off: 64.00 Joules (J) men, = 0.007; 54.70 J women, = 0.001), and mean power (cut-off: 87.8 Watts (W) men, = 0.003; 48.95 W women, = 0.008) in leg extension, as well as the the forearm muscle thickness (cut-off: 1.41 cm (cm) men, = 0.017; 0.94 cm women, = 0.041), had great diagnostic accuracy in both sexes.

Conclusions: The phase angle, peak torque, total work, and mean power in leg extension, as well as forearm muscle thickness, had great diagnostic accuracy in regard to sarcopenia, and the suggested cut-off points could lead to the confirmation of sarcopenia diagnosis, but more studies are needed to confirm this.

Citing Articles

Inhibition of CILP2 Improves Glucose Metabolism and Mitochondrial Dysfunction in Sarcopenia via the Wnt Signalling Pathway.

Deng Z, Song C, Chen L, Zhang R, Yang L, Zhang P J Cachexia Sarcopenia Muscle. 2024; 15(6):2544-2558.

PMID: 39385717 PMC: 11634484. DOI: 10.1002/jcsm.13597.

References
1.
de Moura T, de Almeida Nagata C, Garcia P . The influence of isokinetic peak torque and muscular power on the functional performance of active and inactive community-dwelling elderly: a cross-sectional study. Braz J Phys Ther. 2019; 24(3):256-263. PMC: 7253910. DOI: 10.1016/j.bjpt.2019.03.003. View

2.
Stringer H, Wilson D . The Role of Ultrasound as a Diagnostic Tool for Sarcopenia. J Frailty Aging. 2018; 7(4):258-261. PMC: 6208738. DOI: 10.14283/jfa.2018.24. View

3.
Casey P, Alasmar M, Mclaughlin J, Ang Y, McPhee J, Heire P . The current use of ultrasound to measure skeletal muscle and its ability to predict clinical outcomes: a systematic review. J Cachexia Sarcopenia Muscle. 2022; 13(5):2298-2309. PMC: 9530572. DOI: 10.1002/jcsm.13041. View

4.
Cruz-Jentoft A, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T . Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2018; 48(1):16-31. PMC: 6322506. DOI: 10.1093/ageing/afy169. View

5.
Di Lenarda L, Buoite Stella A, Ratti C, Ruggiero L, Bernard M, Cavarzerani L . Assessing Muscle Mass in the Orthopedic Clinical Setting: Application of the Ultrasound Sarcopenia Index in Elderly Subjects with a Recent Femoral Fracture. Nutrients. 2024; 16(5). PMC: 10934151. DOI: 10.3390/nu16050711. View